Luminescent Materials Laboratory, Department of Biotechnology, University of Verona and INSTM - UdR Verona, Strada Le Grazie 15, 37134 Verona, Italy.
Laboratory of Chemical Technologies, Polytechnic Department of Engineering and Architecture, University of Udine, via Cotonificio 108, 33100 Udine, Italy.
Inorg Chem. 2020 Sep 8;59(17):12564-12577. doi: 10.1021/acs.inorgchem.0c01663. Epub 2020 Aug 10.
The cationic enantiopure () and luminescent Eu(III) complex [Eu(bQcd)(HO)] OTf (with bQcd = -bis(2-quinolinmethyl)--1,2-diaminocyclohexane -diacetate and OTf = triflate) was synthesized and characterized. At physiological pH, the 1:1 [Eu(bQcd)(HO)] species, possessing two water molecules in the inner coordination sphere, is largely dominant. The interaction with bovine serum albumin (BSA) was studied by means of several experimental techniques, such as luminescence spectroscopy, isothermal titration calorimetry (ITC), molecular docking (MD), and molecular dynamics simulations (MDS). In this direction, a ligand competition study was also performed by using three clinically established drugs (i.e., ibuprofen, warfarin, and digitoxin). The nature of this interaction is strongly affected by the type of the involved heteroaromatic antenna in the Eu(III) complexes. In fact, the presence of quinoline rings drives the corresponding complex toward the protein superficial area containing the tryptophan residue 134 (Trp134). As the main consequence, the metal center undergoes the loss of one water molecule upon interaction with the side chain of a glutamic acid residue. On the other hand, the similar complex containing pyridine rings ([Eu(bpcd)(HO)]Cl with bpcd = -bis(2-pyridylmethyl)-trans-1,2-diaminocyclohexane -diacetate) interacts more weakly with the protein in a different superficial cavity, without losing the coordinated water molecules.
手性纯([Eu(bQcd)(HO)]OTf,其中 bQcd = -双(2-喹啉甲基)-1,2-二氨基环己烷-二乙酸酯,OTf = 三氟甲磺酸根)的阳离子对映体和发光 Eu(III)配合物被合成并进行了表征。在生理 pH 下,以 1:1 形式存在的[Eu(bQcd)(HO)]物种,其内部配位球中含有两个水分子,占据主导地位。通过荧光光谱、等温滴定微量热法(ITC)、分子对接(MD)和分子动力学模拟(MDS)等多种实验技术研究了与牛血清白蛋白(BSA)的相互作用。在这个方向上,还通过三种临床应用药物(即布洛芬、华法林和地高辛)进行了配体竞争研究。这种相互作用的性质强烈受到 Eu(III)配合物中涉及的杂芳环天线的类型的影响。事实上,喹啉环的存在使相应的配合物朝向含有色氨酸残基 134(Trp134)的蛋白质表面区域。作为主要结果,金属中心在与谷氨酸残基的侧链相互作用时失去一个水分子。另一方面,含有吡啶环的类似配合物([Eu(bpcd)(HO)]Cl,其中 bpcd = -双(2-吡啶甲基)-trans-1,2-二氨基环己烷-二乙酸酯)以不同的表面腔与蛋白质相互作用较弱,不失去配位水分子。